Mylan Schedules Fourth Quarter and Year End 2012 Financial Results Conference Call and Live Webcast

Mylan Schedules Fourth Quarter and Year End 2012 Financial Results Conference
                            Call and Live Webcast

PR Newswire

PITTSBURGH, Feb. 13, 2013

PITTSBURGH, Feb. 13, 2013 /PRNewswire/ --Mylan Inc. (Nasdaq: MYL) announced
today that it will host a conference call and live webcast, including a slide
presentation, on Wednesday, Feb. 27, 2013, at 5:00 p.m. ET, to review the
company's financial results for the fourth quarter and year ended Dec. 31,
2012. The company also will be providing its financial guidance for 2013.
Mylan will release its financial results on Feb. 27 after the market closes.

The dial-in number to access the call is 877.402.3913 or 817.382.5964 for
international callers. A replay, available for approximately seven days, will
be available at 800.585.8367 or 404.537.3406 for international callers with
access pass code 94045069.

To access a live webcast of the call, please log on to Mylan's Web site
( at least 15 minutes before the event is to begin to register
and download or install any necessary software. A replay of the webcast will
be available on for approximately seven days.

Mylan is a global pharmaceutical company committed to setting new standards in
health care. Working together around the world to provide 7 billion people
access to high quality medicine, we innovate to satisfy unmet needs; make
reliability and service excellence a habit, do what's right, not what's easy
and impact the future through passionate global leadership. We offer a growing
portfolio of more than 1,100 generic pharmaceuticals and several brand
medications. In addition, we offer a wide range of antiretroviral therapies,
upon which approximately one-third of HIV/AIDS patients in developing
countries depend. We also operate one of the largest active pharmaceutical
ingredient manufacturers and currently market products in approximately 150
countries and territories. Our workforce of more than 18,000 people is
dedicated to improving the customer experience and increasing pharmaceutical
access to consumers around the world. But don't take our word for it. See for
yourself. See inside.

SOURCE Mylan Inc.

Contact: Nina Devlin (Media), +1-724-514-1968; Kris King (Investors),
Press spacebar to pause and continue. Press esc to stop.